Report cover image

Global Targeted SSTR Radionuclide Drug Conjugates Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 196 Pages
SKU # APRC20283492

Description

Summary

According to APO Research, The global Targeted SSTR Radionuclide Drug Conjugates market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Targeted SSTR Radionuclide Drug Conjugates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Targeted SSTR Radionuclide Drug Conjugates include Curium Pharma, ITM Radiopharma, RadioMedix, Novartis and Grand Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Targeted SSTR Radionuclide Drug Conjugates, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Targeted SSTR Radionuclide Drug Conjugates, also provides the sales of main regions and countries. Of the upcoming market potential for Targeted SSTR Radionuclide Drug Conjugates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted SSTR Radionuclide Drug Conjugates sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Targeted SSTR Radionuclide Drug Conjugates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Targeted SSTR Radionuclide Drug Conjugates sales, projected growth trends, production technology, application and end-user industry.

Targeted SSTR Radionuclide Drug Conjugates Segment by Company

Curium Pharma
ITM Radiopharma
RadioMedix
Novartis
Grand Pharmaceutical
Targeted SSTR Radionuclide Drug Conjugates Segment by Type

Diagnostic
Therapeutic
Targeted SSTR Radionuclide Drug Conjugates Segment by Application

Hospital
Specialist Clinic
Other
Targeted SSTR Radionuclide Drug Conjugates Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted SSTR Radionuclide Drug Conjugates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted SSTR Radionuclide Drug Conjugates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted SSTR Radionuclide Drug Conjugates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Targeted SSTR Radionuclide Drug Conjugates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Targeted SSTR Radionuclide Drug Conjugates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted SSTR Radionuclide Drug Conjugates sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Targeted SSTR Radionuclide Drug Conjugates Market by Type
1.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Targeted SSTR Radionuclide Drug Conjugates Market by Application
1.3.1 Global Targeted SSTR Radionuclide Drug Conjugates Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Targeted SSTR Radionuclide Drug Conjugates Market Dynamics
2.1 Targeted SSTR Radionuclide Drug Conjugates Industry Trends
2.2 Targeted SSTR Radionuclide Drug Conjugates Industry Drivers
2.3 Targeted SSTR Radionuclide Drug Conjugates Industry Opportunities and Challenges
2.4 Targeted SSTR Radionuclide Drug Conjugates Industry Restraints
3 Global Market Growth Prospects
3.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Estimates and Forecasts (2020-2031)
3.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region
3.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2020-2025)
3.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Region (2026-2031)
3.2.4 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Region (2020-2031)
3.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Estimates and Forecasts 2020-2031
3.4 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region
3.4.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2020-2025)
3.4.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Region (2026-2031)
3.4.4 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Manufacturers
4.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Manufacturers (2020-2025)
4.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Manufacturers
4.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Manufacturers (2020-2025)
4.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Price by Manufacturers (2020-2025)
4.4 Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Targeted SSTR Radionuclide Drug Conjugates Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers, Product Type & Application
4.7 Global Targeted SSTR Radionuclide Drug Conjugates Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Targeted SSTR Radionuclide Drug Conjugates Market CR5 and HHI
4.8.2 2024 Targeted SSTR Radionuclide Drug Conjugates Tier 1, Tier 2, and Tier 3
5 Targeted SSTR Radionuclide Drug Conjugates Market by Type
5.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type
5.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Type (2020-2031)
5.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type
5.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031) & (K Units)
5.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Type (2020-2031)
5.3 Global Targeted SSTR Radionuclide Drug Conjugates Price by Type
6 Targeted SSTR Radionuclide Drug Conjugates Market by Application
6.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application
6.1.1 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Targeted SSTR Radionuclide Drug Conjugates Revenue Market Share by Application (2020-2031)
6.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application
6.2.1 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031) & (K Units)
6.2.3 Global Targeted SSTR Radionuclide Drug Conjugates Sales Market Share by Application (2020-2031)
6.3 Global Targeted SSTR Radionuclide Drug Conjugates Price by Application
7 Company Profiles
7.1 Curium Pharma
7.1.1 Curium Pharma Comapny Information
7.1.2 Curium Pharma Business Overview
7.1.3 Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Curium Pharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
7.1.5 Curium Pharma Recent Developments
7.2 ITM Radiopharma
7.2.1 ITM Radiopharma Comapny Information
7.2.2 ITM Radiopharma Business Overview
7.2.3 ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 ITM Radiopharma Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
7.2.5 ITM Radiopharma Recent Developments
7.3 RadioMedix
7.3.1 RadioMedix Comapny Information
7.3.2 RadioMedix Business Overview
7.3.3 RadioMedix Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 RadioMedix Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
7.3.5 RadioMedix Recent Developments
7.4 Novartis
7.4.1 Novartis Comapny Information
7.4.2 Novartis Business Overview
7.4.3 Novartis Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Novartis Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
7.4.5 Novartis Recent Developments
7.5 Grand Pharmaceutical
7.5.1 Grand Pharmaceutical Comapny Information
7.5.2 Grand Pharmaceutical Business Overview
7.5.3 Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Grand Pharmaceutical Targeted SSTR Radionuclide Drug Conjugates Product Portfolio
7.5.5 Grand Pharmaceutical Recent Developments
8 North America
8.1 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
8.1.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031)
8.1.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031)
8.1.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Type (2020-2031)
8.2 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
8.2.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031)
8.2.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031)
8.2.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Application (2020-2031)
8.3 North America Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
8.3.1 North America Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Targeted SSTR Radionuclide Drug Conjugates Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
9.1.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031)
9.1.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031)
9.1.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Type (2020-2031)
9.2 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
9.2.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031)
9.2.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031)
9.2.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Application (2020-2031)
9.3 Europe Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
9.3.1 Europe Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Targeted SSTR Radionuclide Drug Conjugates Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
10.1.1 China Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031)
10.1.2 China Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031)
10.1.3 China Targeted SSTR Radionuclide Drug Conjugates Price by Type (2020-2031)
10.2 China Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
10.2.1 China Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031)
10.2.2 China Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031)
10.2.3 China Targeted SSTR Radionuclide Drug Conjugates Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
11.1.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031)
11.1.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031)
11.1.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Type (2020-2031)
11.2 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
11.2.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031)
11.2.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031)
11.2.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Application (2020-2031)
11.3 Asia Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
11.3.1 Asia Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Targeted SSTR Radionuclide Drug Conjugates Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Type
12.1.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Type (2020-2031)
12.1.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Type (2020-2031)
12.1.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Type (2020-2031)
12.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Application
12.2.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue by Application (2020-2031)
12.2.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Application (2020-2031)
12.2.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Application (2020-2031)
12.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Market Size by Country
12.3.1 SAMEA Targeted SSTR Radionuclide Drug Conjugates Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Targeted SSTR Radionuclide Drug Conjugates Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Targeted SSTR Radionuclide Drug Conjugates Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Targeted SSTR Radionuclide Drug Conjugates Value Chain Analysis
13.1.1 Targeted SSTR Radionuclide Drug Conjugates Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Targeted SSTR Radionuclide Drug Conjugates Production Mode & Process
13.2 Targeted SSTR Radionuclide Drug Conjugates Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Targeted SSTR Radionuclide Drug Conjugates Distributors
13.2.3 Targeted SSTR Radionuclide Drug Conjugates Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.